Nalaganje...
Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab
Pembrolizumab is a programmed cell death protein 1 (PD-1) monoclonal antibody used in the treatment of metastatic melanomas. Severe ocular complications appear in less than 1% of the patients and require early treatment. We present the case of a patient diagnosed with a BRAF mutated metastatic melan...
Shranjeno v:
| izdano v: | Indian J Ophthalmol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer - Medknow
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6896544/ https://ncbi.nlm.nih.gov/pubmed/31755465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijo.IJO_1161_19 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|